Abstract
MicroRNAs (miRNAs) are an emerging class of highly conserved, non-coding small RNAs that regulate gene expression on the post-transcriptional level by inhibiting the translation of protein from mRNA or by promoting the degradation of mRNA. The involvement of miRNAs in the regulation of lipid metabolism, inflammatory response, cell cycle progression and proliferation, oxidative stress, platelet activation, endothelial function, angiogenesis and plaque formation and rapture indicates important roles in the initiation and progression of atherosclerosis. In the light of this evidence we will review the role of miRNAs in atherosclerosis.
Keywords: microRNAs, atherosclerosis, inflammation, endothelial function.
Current Topics in Medicinal Chemistry
Title:MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
Volume: 13 Issue: 13
Author(s): Gerasimos Siasos, Christina Kollia, Vasiliki Tsigkou, Efthimia K. Basdra, Maria Lymperi, Evangelos Oikonomou, Eleni Kokkou, Porfyrios Korompelis and Athanasios G. Papavassiliou
Affiliation:
Keywords: microRNAs, atherosclerosis, inflammation, endothelial function.
Abstract: MicroRNAs (miRNAs) are an emerging class of highly conserved, non-coding small RNAs that regulate gene expression on the post-transcriptional level by inhibiting the translation of protein from mRNA or by promoting the degradation of mRNA. The involvement of miRNAs in the regulation of lipid metabolism, inflammatory response, cell cycle progression and proliferation, oxidative stress, platelet activation, endothelial function, angiogenesis and plaque formation and rapture indicates important roles in the initiation and progression of atherosclerosis. In the light of this evidence we will review the role of miRNAs in atherosclerosis.
Export Options
About this article
Cite this article as:
Siasos Gerasimos, Kollia Christina, Tsigkou Vasiliki, Basdra K. Efthimia, Lymperi Maria, Oikonomou Evangelos, Kokkou Eleni, Korompelis Porfyrios and Papavassiliou G. Athanasios, MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis, Current Topics in Medicinal Chemistry 2013; 13(13) . https://dx.doi.org/10.2174/15680266113139990099
DOI https://dx.doi.org/10.2174/15680266113139990099 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Nano-constructed Carriers Loaded With Antioxidant: Boon For Cardiovascular System
Current Pharmaceutical Design Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Beta-2 Agonists in Asthma: Medicine or Murderer?
Current Respiratory Medicine Reviews Preface
Current Pharmaceutical Design Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists
Current Pharmaceutical Design Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Use of Bipolar Radiofrequency Catheter Ablation in the Treatment of Cardiac Arrhythmias
Current Cardiology Reviews Editorial (Thematic Issue Cells and Gene Therapy - “Do You Like Green Eggs and Ham?”)
Current Gene Therapy Highly Active Antiretroviral Therapy-Induced Liver Injury
Current Drug Safety Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry The Concept of Titration can be Transposed to Fluid Management. But does is Change the Volumes? Randomised Trial on Pleth Variability Index During Fast-Track Colonic Surgery
Current Clinical Pharmacology The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury
Current Pharmaceutical Design An Insight of Novel Pharmacological Therapies in Hypertrophic Cardiomyopathy
Medicinal Chemistry Potential Risks and Mitigation Strategies Before the Conduct of a Clinical Trial: An Industry Perspective
Reviews on Recent Clinical Trials Advantages and Limitations of Transgenic Mice: The Role of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Cardiac Electrophysiology and Arrhythmia
Current Medicinal Chemistry Speculative Considerations about Some Cardiology Enigmas
Current Cardiology Reviews The Therapeutic Potential of PhospholipaseA2 Inhibitors in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Humic Acids as Therapeutic Compounds in Lead Intoxication
Current Clinical Pharmacology COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews